Letters to the Editor nesium subsequently stabilised at the lower end of the reference range (figure), and no further intravenous magnesium replacement was required.
Comment
Calcium and magnesium share a transport system in the gut, and both 1-a-hydroxycholecalciferol and 1,25 dihydroxycholecalciferol have been successfully used in the treatment of hypomagnesaemia associated with the short bowel syndrome.2 A recent report describes the use of l-a-cholecalciferol in a patient with the short bowel syndrome in whom, the authors claim, renal tubular absorption of magnesium was increased.3
In our case oral magnesium supplements in high doses were associated with diarrhoea, and I-a-hydroxycholecalciferol enhanced magnesium absorption and possibly reduced urinary losses. The figure shows that normal serum magnesium concentrations were maintained after the administration of 1-acholecalciferol, with resolution of symptoms. Two 24 hour collections obtained while the patient was taking 1-a-cholecalciferol contained 5 and 8 mmol magnesium (figure), suggesting that any effect of 1-a-cholecalciferol on renal magnesium conservation was minimal. presumably, secreted into the fluid.3 As only very low concentrations of active renin are found in the ovary, it has been postulated that ovarian prorenin may be biologically active without any necessity for prior removal of the propart sequence.' The role of ovarian prorenin is still unclear but it probably operates through the formation of angiotensin II (AII). Studies with the AII antagonist, saralasin, have indicated a direct role for AII in ovulation,4 and, in addition to its effects on steroidogenesis, the vasoconstrictor and angiogenic properties may be important for follicular growth. Cysts are commonly derived from the ovarian follicles and frequently contain a large volume of liquid. It was thus considered of interest to determine whether this fluid might also contain a high concentration of prorenin. The fluid from six ovarian cysts removed at laparotomy was collected, stored at -20°C, and assayed for prorenin by the trypsin-activation method of McIntyre et al.' Renin activity was estimated by measuring the rate of angiotensin I (AI) production from human angiotensinogen.6
Prorenin was detected in the fluid from four of the cysts assayed-three of follicular origin and one from a mucinous cystadenoma-with two others being virtually negative (table) . The concentration of active renin detected in all of the fluids was very low (less than 5 0 of total) and may have been due to partial activation of the prorenin during collection. This predominance of prorenin over renin is in keeping with previous results for normal ovarian follicular fluid.' 2 Concentrations ofprorenin in ovarian cyst fluid Prorenin Age Diagnosis (ng Al/mi/h)
